Ignite Creation Date:
2024-05-05 @ 10:22 PM
Last Modification Date:
2024-10-26 @ 10:18 AM
Study NCT ID:
NCT01095757
Status:
COMPLETED
Last Update Posted:
2014-09-29
First Post:
2010-03-26
Brief Title:
Evaluation of the Drug Plerixafor in Combination With Chemotherapy and G-CSF for Stem Cell Collection
Sponsor:
Emory University
Organization:
Emory University
Study Overview
Official Title:
Evaluation of Plerixafor Mozobil AMD3100 in Combination With Chemotherapy and G-CSF for CD34 Cell Mobilization
Status:
COMPLETED
Status Verified Date:
2014-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to test whether the addition of the drug plerixafor to treatment with chemotherapy and G-CSF can better activate your bone marrow stem cells to improve the chances of transplant The study will look for the activation of a certain type of blood cell called CD34 cells in patients who receive plerixafor chemotherapy and G-CSF The investigators will follow the number of patients that achieve the target numbers of CD34 cells The number of patients achieving the target level of CD34 cells and the total number of CD34 cells will be compared to the numbers in previous studies testing just chemotherapy and G-CSF without plerixafor
The investigators will also test the safety of the combination of plerixafor with chemotherapy and G-CSF and look at the success of the transplantation after 12 months
The investigators will also test the safety of the combination of plerixafor with chemotherapy and G-CSF and look at the success of the transplantation after 12 months
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| WCI1671-09 | OTHER | Other | None |